SGLT2 Inhibitors Can Improve Anemia in Patients with CKD hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.
Preliminary findings demonstrate an improvement in eGFR slope in nearly all patients with SCD after treatment with SGLT-2 inhibitors and GLP-1 receptor agonists.
Everly Health has formed a partnership with the National Kidney Foundation to improve education about chronic kidney disease. It has also expanded its diabetes monitoring and kidney health testing suite for health plans and employers.
Our most-read articles on diabetes covered racial biases in type 2 diabetes risk prediction models, cardiovascular disease as a leading cause of hospital admissions in patients with diabetes, and much more.